1763.HKライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (28 6月 2024 @ 16:59):
Our systems believe the stock currently is overvalued by -0.04% compare to its pairs and should correct downwards.

Stats
本日の出来高	347 400
平均出来高	175 455
時価総額	3.32B
EPS	HKD0.760 ( Q4 \| 2023-12-31 )
Last Dividend	HKD0.479 ( 2023-07-04 )
Next Dividend	HKD0 ( N/A )
P/E	8.06 (Sector) 14.27 (Industry) 0
ATR14	HKD0.0420 (0.42%)

0853.HK -4.70%

1612.HK -1.18%

1696.HK 1.69%

1763.HK -2.33%

1789.HK -0.92%

1858.HK -0.92%

2160.HK 0.00%

2170.HK -3.59%

2190.HK 1.73%

2216.HK 1.69%

2235.HK -0.26%

2252.HK -4.24%

2393.HK 2.27%

2500.HK -0.71%

6118.HK -2.86%

6609.HK 0.00%

6669.HK 3.64%

9996.HK -5.00%

相関 (AI algo v.1.1b): Overvalued: -0.04% HKD10.08 paired level. (アルゴリズムは、最も相関の高い株式の変更をリアルタイムで追跡し、即時の更新を提供します)

China Isotope & Radiation 相関

10 最も正の相関

10 最も負の相関

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

China Isotope & Radiation 相関 - 通貨/商品

0.03
( neutral )

-0.25
( neutral )

0.00
( neutral )

-0.06
( neutral )

0.00
( neutral )

0.66
( moderate )

China Isotope & Radiation 財務諸表

Annual	2023
収益:	HKD6.63B
総利益:	HKD3.48B (52.48 %)
EPS:	HKD1.160

FY	2023
収益:	HKD6.63B
総利益:	HKD3.48B (52.48 %)
EPS:	HKD1.160

FY	2022
収益:	HKD6.15B
総利益:	HKD3.51B (57.18 %)
EPS:	HKD1.220

FY	2021
収益:	HKD5.14B
総利益:	HKD3.24B (63.03 %)
EPS:	HKD1.050

Financial Reports:

No articles found.

China Isotope & Radiation Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.479 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

China Isotope & Radiation Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 9.12 - good (91.23%) | Divividend Growth Potential Score: 4.44 - Stable (11.27%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.169	2018-11-28
Last Dividend	HKD0.479	2023-07-04
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	6	--
Total Paid Out	HKD1.597	--
Avg. Dividend % Per Year	0.00%	--
Score	2.59	--
Div. Sustainability Score	9.12
Div.Growth Potential Score	4.44
Div. Directional Score	6.78	--

Next Divdend (Est)
(2025-04-17)

HKD0.564 Estimate 3.10 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.59

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Dividend History

Ex Date	Amount	Declaration Date	Record Date	Payment Date
04 Jul 2023	HKD0.479	30 Nov -0001	30 Nov -0001	30 Nov -0001
25 May 2022	HKD0.440	30 Nov -0001	30 Nov -0001	30 Nov -0001
17 May 2021	HKD0.217	30 Nov -0001	30 Nov -0001	30 Nov -0001
06 Jul 2020	HKD0.152	31 Mar 2020	07 Jul 2020	28 Aug 2020
03 Jul 2019	HKD0.139	29 Mar 2019	04 Jul 2019	28 Aug 2019
28 Nov 2018	HKD0.169	29 Aug 2018	29 Nov 2018	31 Jan 2019

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
2001.HK	Ex Dividend Junior	2023-09-01	Annually	0.00%
0435.HK	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%
1571.HK	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
0071.HK	Ex Dividend Knight	2023-09-25	Semi-Annually	0.00%
6190.HK	Ex Dividend Junior	2023-07-03	Annually	0.00%
1072.HK	Ex Dividend Junior	2023-06-30	Sporadic	0.00%
2327.HK	Ex Dividend Junior	2023-08-03	Sporadic	0.00%
0669.HK	Ex Dividend Knight	2023-08-29	Semi-Annually	0.00%
1821.HK	Ex Dividend Junior	2023-09-07	Semi-Annually	0.00%
0251.HK	Ex Dividend Junior	2023-09-20	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0559	1.500	8.88	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0281	1.200	9.06	10.00	[0 - 0.3]
returnOnEquityTTM	0.0811	1.500	-0.210	-0.315	[0.1 - 1]
payoutRatioTTM	0.380	-1.000	6.20	-6.20	[0 - 1]
currentRatioTTM	1.926	0.800	5.37	4.29	[1 - 3]
quickRatioTTM	1.603	0.800	5.28	4.22	[0.8 - 2.5]
cashRatioTTM	0.675	1.500	7.36	10.00	[0.2 - 2]
debtRatioTTM	0.129	-1.500	7.86	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.266	2.00	9.91	10.00	[0 - 30]
freeCashFlowPerShareTTM	-2.54	2.00	-1.270	-2.54	[0 - 20]
debtEquityRatioTTM	0.361	-1.500	8.55	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.525	1.000	4.59	4.59	[0.2 - 0.8]
operatingProfitMarginTTM	0.113	1.000	9.74	9.74	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0501	1.000	-0.833	-0.833	[0.2 - 2]
assetTurnoverTTM	0.503	0.800	9.98	7.98	[0.5 - 2]
Total Score				9.12

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	8.19	1.000	9.27	0	[1 - 100]
returnOnEquityTTM	0.0811	2.50	-0.135	-0.315	[0.1 - 1.5]
freeCashFlowPerShareTTM	-2.54	2.00	-0.847	-2.54	[0 - 30]
dividendYielPercentageTTM	11.96	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.266	2.00	9.91	10.00	[0 - 30]
payoutRatioTTM	0.380	1.500	6.20	-6.20	[0 - 1]
pegRatioTTM	0.640	1.500	9.06	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0128	1.000	-2.18	0	[0.1 - 0.5]
Total Score				4.44

China Isotope & Radiation Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

China Isotope & Radiation

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Independent Clinical Medical and Laboratory Services, and Other Business. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; UBT kits and analyzers; and in vitro immunoassay diagnostic reagents and kits. The Radioactive Source Products segment provides medical and industrial radioactive sources products and related technical services. The Irradiation segment offers irradiation services to manufacturers of medical devices, food, traditional Chinese medicine, and cosmetics for sterilization; and EPC services for the design, manufacturing, and installation of gamma ray irradiation facilities. The Radiation Therapy Equipment and Related Services segment sells radiation therapy equipment; and provides related maintenance services. The Independent Clinical Medical and Laboratory Services, and Other Business segment provides independent clinical laboratory services with respect to hepatitis, endocrine, bone metabolism, cardiovascular disease, diabetes, and other diseases to hospitals and other medical institutions. The company was founded in 1983 and is headquartered in Beijing, China. China Isotope & Radiation Corporation is a subsidiary of China National Nuclear Corporation.